FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307925716> ?p ?o ?g. }

• W4307925716 endingPage "e061870" @default.
• W4307925716 startingPage "e061870" @default.
• W4307925716 abstract "Introduction Long COVID-19, where symptoms persist 12 weeks after the initial SARS-CoV-2-infection, is a substantial problem for individuals and society in the surge of the pandemic. Common symptoms are fatigue, postexertional malaise and cognitive dysfunction. There is currently no effective treatment and the underlying mechanisms are unknown, although several hypotheses exist, with chronic inflammation as a common denominator. In prospective studies, hyperbaric oxygen therapy (HBOT) has been suggested to be effective for the treatment of similar syndromes such as chronic fatigue syndrome and fibromyalgia. A case series has suggested positive effects of HBOT in long COVID-19. This randomised, placebo-controlled clinical trial will explore HBOT as a potential treatment for long COVID-19. The primary objective is to evaluate if HBOT improves health-related quality of life (HRQoL) for patients with long COVID-19 compared with placebo/sham. The main secondary objective is to evaluate whether HBOT improves endothelial function, objective physical performance and short-term HRQoL. Methods and analysis A randomised, placebo-controlled, double-blind, phase II clinical trial in 80 previously healthy subjects debilitated due to long COVID-19, with low HRQoL. Clinical data, HRQoL questionnaires, blood samples, objective tests and activity metre data will be collected at baseline. Subjects will be randomised to a maximum of 10 treatments with hyperbaric oxygen or sham treatment over 6 weeks. Assessments for safety and efficacy will be performed at 6, 13, 26 and 52 weeks, with the primary endpoint (physical domains in RAND 36-Item Health Survey) and main secondary endpoints defined at 13 weeks after baseline. Data will be reviewed by an independent data safety monitoring board. Ethics and dissemination The trial is approved by the Swedish National Institutional Review Board (2021–02634) and the Swedish Medical Products Agency (5.1-2020-36673). Positive, negative and inconclusive results will be published in peer-reviewed scientific journals with open access. Trial registration number NCT04842448 ." @default.
• W4307925716 created "2022-11-06" @default.
• W4307925716 creator A5001065582 @default.
• W4307925716 creator A5003545645 @default.
• W4307925716 creator A5006774200 @default.
• W4307925716 creator A5009425199 @default.
• W4307925716 creator A5017637420 @default.
• W4307925716 creator A5021108404 @default.
• W4307925716 creator A5030569559 @default.
• W4307925716 creator A5046685193 @default.
• W4307925716 creator A5047774923 @default.
• W4307925716 creator A5049279780 @default.
• W4307925716 creator A5050380848 @default.
• W4307925716 creator A5061937228 @default.
• W4307925716 creator A5064143707 @default.
• W4307925716 creator A5069329974 @default.
• W4307925716 creator A5070392758 @default.
• W4307925716 creator A5073288771 @default.
• W4307925716 creator A5086702884 @default.
• W4307925716 creator A5088697198 @default.
• W4307925716 date "2022-11-01" @default.
• W4307925716 modified "2023-10-05" @default.
• W4307925716 title "Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial" @default.
• W4307925716 cites W1509422947 @default.
• W4307925716 cites W156640090 @default.
• W4307925716 cites W1994222210 @default.
• W4307925716 cites W2060886633 @default.
• W4307925716 cites W2098430882 @default.
• W4307925716 cites W2118652077 @default.
• W4307925716 cites W2130267399 @default.
• W4307925716 cites W2152176691 @default.
• W4307925716 cites W2189615875 @default.
• W4307925716 cites W2324439047 @default.
• W4307925716 cites W2598707759 @default.
• W4307925716 cites W2782908833 @default.
• W4307925716 cites W2787497572 @default.
• W4307925716 cites W2805554747 @default.
• W4307925716 cites W2973816242 @default.
• W4307925716 cites W3015197361 @default.
• W4307925716 cites W3025056678 @default.
• W4307925716 cites W3080407822 @default.
• W4307925716 cites W3085847973 @default.
• W4307925716 cites W3119322361 @default.
• W4307925716 cites W3123099249 @default.
• W4307925716 cites W3124849444 @default.
• W4307925716 cites W3133623762 @default.
• W4307925716 cites W3138204218 @default.
• W4307925716 cites W3175097477 @default.
• W4307925716 cites W3177257563 @default.
• W4307925716 cites W3182857280 @default.
• W4307925716 cites W3184339862 @default.
• W4307925716 cites W3188317265 @default.
• W4307925716 cites W3193495739 @default.
• W4307925716 cites W3215922138 @default.
• W4307925716 cites W3217743982 @default.
• W4307925716 cites W4200091136 @default.
• W4307925716 cites W4200188493 @default.
• W4307925716 cites W4213300961 @default.
• W4307925716 cites W97622595 @default.
• W4307925716 doi "https://doi.org/10.1136/bmjopen-2022-061870" @default.
• W4307925716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36323462" @default.
• W4307925716 hasPublicationYear "2022" @default.
• W4307925716 type Work @default.
• W4307925716 citedByCount "7" @default.
• W4307925716 countsByYear W43079257162022 @default.
• W4307925716 countsByYear W43079257162023 @default.
• W4307925716 crossrefType "journal-article" @default.
• W4307925716 hasAuthorship W4307925716A5001065582 @default.
• W4307925716 hasAuthorship W4307925716A5003545645 @default.
• W4307925716 hasAuthorship W4307925716A5006774200 @default.
• W4307925716 hasAuthorship W4307925716A5009425199 @default.
• W4307925716 hasAuthorship W4307925716A5017637420 @default.
• W4307925716 hasAuthorship W4307925716A5021108404 @default.
• W4307925716 hasAuthorship W4307925716A5030569559 @default.
• W4307925716 hasAuthorship W4307925716A5046685193 @default.
• W4307925716 hasAuthorship W4307925716A5047774923 @default.
• W4307925716 hasAuthorship W4307925716A5049279780 @default.
• W4307925716 hasAuthorship W4307925716A5050380848 @default.
• W4307925716 hasAuthorship W4307925716A5061937228 @default.
• W4307925716 hasAuthorship W4307925716A5064143707 @default.
• W4307925716 hasAuthorship W4307925716A5069329974 @default.
• W4307925716 hasAuthorship W4307925716A5070392758 @default.
• W4307925716 hasAuthorship W4307925716A5073288771 @default.
• W4307925716 hasAuthorship W4307925716A5086702884 @default.
• W4307925716 hasAuthorship W4307925716A5088697198 @default.
• W4307925716 hasBestOaLocation W43079257161 @default.
• W4307925716 hasConcept C126322002 @default.
• W4307925716 hasConcept C142724271 @default.
• W4307925716 hasConcept C159110408 @default.
• W4307925716 hasConcept C168563851 @default.
• W4307925716 hasConcept C1862650 @default.
• W4307925716 hasConcept C187212893 @default.
• W4307925716 hasConcept C197934379 @default.
• W4307925716 hasConcept C203092338 @default.
• W4307925716 hasConcept C204787440 @default.
• W4307925716 hasConcept C27081682 @default.
• W4307925716 hasConcept C2779277585 @default.
• W4307925716 hasConcept C2779951463 @default.

• next